Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹93 Cr₹73 Cr₹69 Cr₹62 Cr₹51 Cr

What is the latest Consolidated Net Profit of LINCOLN PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of LINCOLN PHARMACEUTICALS is ₹93 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹93 Cr
Mar2024₹73 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2021₹51 Cr

How is Consolidated Net Profit of LINCOLN PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹93 Cr
27.99
Mar2024 ₹73 Cr
5.11
Mar2023 ₹69 Cr
11.41
Mar2022 ₹62 Cr
21.02
Mar2021 ₹51 Cr -

Compare Consolidated Net Profit of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,185.5 Cr -1% -4.1% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1%

-4.1%

5.7%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses